UA026
/ Usynova
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Usynova Pharmaceuticals Ltd.
New P1 trial • Dermatology • Immunology • Psoriasis
1 to 1
Of
1
Go to page
1